BiotechTube
Home/RNAimmune/Dong Shen
DS

Dong Shen

Chief Executive Officer

RNAimmune

Therapeutic Areas

OncologyInfectious DiseasesRare Diseases

RNAimmune Pipeline

DrugIndicationPhase
RV-1770Respiratory Syncytial Virus (RSV) ProphylaxisPhase 1
RV-1730COVID-19 BoosterPhase 1
mRNA Cancer VaccinesOncology (Neoantigen-based)Pre-clinical

Leadership Team at RNAimmune

Z(
Zhifeng (Steven) Long
Chief Science Officer
View full RNAimmune profile